These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7529222)

  • 1. Current state of interferon therapy for chronic hepatitis C.
    Iino S; Hino K; Yasuda K
    Intervirology; 1994; 37(2):87-100. PubMed ID: 7529222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prompt decrease of circulating hepatitis C virus in patients with chronic hepatitis C after treatment with interferon.
    Saitoh H; Naitoh S; Okamoto H; Akahane Y
    J Interferon Res; 1994 Oct; 14(5):239-44. PubMed ID: 7532200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study for relapse cases of chronic hepatitis C treated with interferon (IFN) and approach to more successful re-treatment of IFN].
    Iwabuchi S; Yoshida H; Fukui S
    Nihon Rinsho; 1994 Jul; 52(7):1810-6. PubMed ID: 7521423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The indication and the evaluation of IFN treatment of chronic hepatitis C].
    Yano M
    Nihon Rinsho; 1994 Jul; 52(7):1778-83. PubMed ID: 7521417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of hepatitis C virus RNA in liver tissue as a predictive marker of the response to interferon therapy in chronic hepatitis C.
    Hasui T; Shimomura H; Tsuji H; Wato M; Tsuji T
    Acta Med Okayama; 1994 Jun; 48(3):151-7. PubMed ID: 7524269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors useful in predicting the response to interferon therapy in chronic hepatitis C.
    Tsubota A; Chayama K; Arase Y; Koida I; Saitoh S; Ikeda K; Iwasaki S; Matsumoto T; Kobayashi M; Kumada H
    J Gastroenterol Hepatol; 1993; 8(6):535-9. PubMed ID: 7506584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Examination in clinical course of HCV in interferon treatment].
    Kumada H
    Nihon Rinsho; 1994 Jul; 52(7):1832-5. PubMed ID: 7521426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis.
    Mochida S; Ohnishi K; Matsuo S; Kakihara K; Fujiwara K
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):371A-377A. PubMed ID: 8986241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problems on interferon therapy of chronic hepatitis C].
    Miyaki K; Yamanaka M
    Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):252-8. PubMed ID: 7525801
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prediction of the outcome of IFN therapy in type C chronic hepatitis from serological grouping of hepatitis C virus].
    Sakai A; Yanagi M; Unoura M; Kobayashi K
    Nihon Rinsho; 1994 Jul; 52(7):1759-62. PubMed ID: 7521415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum HCV-RNA for evaluation of interferon-readministration to the former non responders in chronic hepatitis C].
    Sata M; Tanikawa K
    Nihon Rinsho; 1994 Jul; 52(7):1804-9. PubMed ID: 7521422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early negative tests for serum HCV RNA as a predictor of sustained response to interferon therapy in patients with chronic hepatitis C.
    Marcellin P; Martinot M; Erlinger S
    Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):237-8. PubMed ID: 9096422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
    Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum levels of HCV-RNA determined by branched DNA (bDNA) probe assay in chronic hepatitis C: method and clinical significance on interferon (IFN) therapy].
    Osada T; Iwabuchi S; Takatori M; Murayama M; Iino S
    Nihon Rinsho; 1994 Jul; 52(7):1747-53. PubMed ID: 7521414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.
    Hopf U; Berg T; König V; Küther S; Heuft HG; Lobeck H
    J Hepatol; 1996; 24(2 Suppl):67-73. PubMed ID: 8836892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis].
    Karino Y
    Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sequential monitoring of various HCV-related markers in chronic hepatitis C with interferon treatment].
    Nagayama R; Shoji S; Miyake K
    Nihon Rinsho; 1994 Jul; 52(7):1789-93. PubMed ID: 7521419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of retreatment of chronic hepatitis C with interferon (IFN) for non-complete responders on initial treatment].
    Toyoda H; Nakano S; Kumada T
    Nihon Rinsho; 1994 Jul; 52(7):1798-803. PubMed ID: 7521421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retreatment of chronic hepatitis C with interferon.
    Toyoda H; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Suga T; Ohki H; Ito O
    Am J Gastroenterol; 1994 Sep; 89(9):1453-7. PubMed ID: 7521572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.